Ethical, Legal and Social Aspects of the Psychedelic Renaissance
We are a group of researchers with expertise in psychiatry, philosophy, law, ethics, anthropology, and the social sciences that explores the implications of the return of psychedelics into medicine. Our research project, called PsychedELSI, is coordinated at the Charité – Universitätsmedizin Berlin and funded by the German Ministry of Education and Research (BMBF) from 2023 to 2026.
We will share our research and topical information here at our personal academic website. Please understand that we cannot provide you with medical information or access to psychedelic treatments.
Project News
10.25. New Paper:
Caporuscio, C., Poppe, C., Gieselmann, A. and Repantis, D., 2025. Ethical issues with psychedelic-assisted treatments in psychiatry: A systematic scoping review. Psychological Medicine, 55, p.e284. https://doi.org/10.1017/S0033291725101761
09.25. New Paper:
Langlitz, N. (2025). Experiments in medicalization: psychedelic therapy in Switzerland and Australia. BioSocieties, 1-25. https://doi.org/10.1057/s41292-025-00369-y
06.25. New Paper:
Poppe, C., Bublitz, J. C., & Repantis, D. (2025). Offering Psychedelic Treatments Before Assisted Dying for Psychiatric Conditions. JAMA psychiatry. https://doi.org/10.1001/jamapsychiatry.2025.1457
04.25. New Paper:
Poppe C, Villiger D, Repantis D*, Trachsel M* (2025) Mitigating Ethical Issues in Training for Psychedelic Therapy. Neuroethics 18, 25 (2025). https://doi.org/10.1007/s12152-025-09596-3
02.25. Media Coverage:
Können psychoaktive Pilze gegen Depressionen helfen? SPIEGEL (interview Repantis)
01.25. New Paper:
Yoo, M., & Sakopoulos, S. (2025). The Birth of the Psychedelic Industry: Capitalising on the Psychedelic Renaissance. Future Humanities, 3(1), e70004. https://doi.org/10.1002/fhu2.70004
